Cosmo Bio Company,Limited Company Description
Cosmo Bio Company,Limited, together with its subsidiaries, engages in the purchase and sale of research reagents, equipment, and contract services related to life science worldwide.
The company distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and gene analysis systems; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software.It also provides drug discovery and custom research services; clinical diagnostics; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production services.
In addition, the company manufactures and sells cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement and staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; and biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate.
It serves universities, public research institutes, and companies engaged in biological science. Cosmo Bio Company, Limited was founded in 1978 and is headquartered in Koto, Japan.
| Country | Japan |
| Founded | 1978 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 174 |
| CEO | Norihiko Shibayama |
Contact Details
Address: Toyo-Ekimae Bldg. Koto, 135-0016 Japan | |
| Phone | 81 3 5632 9600 |
| Website | cosmobio.co.jp |
Stock Details
| Ticker Symbol | 3386 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3298700000 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Norihiko Shibayama | Chief Executive Officer |
| Masanori Hayashi | Chief Financial Officer |